153 related articles for article (PubMed ID: 11131921)
21. Monitoring of hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation (alloSCT) by dual-color FISH analysis of X and Y chromosomes.
Turkiewicz D; Gorczynska E; Toporski J; Kalwak K; Rybka B; Noworolska D; Boguslawska-Jaworska J; Chybicka A
Leuk Res; 2003 Nov; 27(11):993-8. PubMed ID: 12859992
[TBL] [Abstract][Full Text] [Related]
22. Clinical Utility of Quantitative PCR for Chimerism and Engraftment Monitoring after Allogeneic Stem Cell Transplantation for Hematologic Malignancies.
Ahci M; Stempelmann K; Buttkereit U; Crivello P; Trilling M; Heinold A; Steckel NK; Koldehoff M; Horn PA; Beelen DW; Fleischhauer K
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1658-1668. PubMed ID: 28603070
[TBL] [Abstract][Full Text] [Related]
23. Early mixed T-cell chimerism is predictive of pediatric AML or MDS relapse after hematopoietic stem cell transplant.
Broglie L; Helenowski I; Jennings LJ; Schafernak K; Duerst R; Schneiderman J; Tse W; Kletzel M; Chaudhury S
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28266766
[TBL] [Abstract][Full Text] [Related]
24. Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
DeAngelo DJ; Hochberg EP; Alyea EP; Longtine J; Lee S; Galinsky I; Parekkedon B; Ritz J; Antin JH; Stone RM; Soiffer RJ
Clin Cancer Res; 2004 Aug; 10(15):5065-71. PubMed ID: 15297408
[TBL] [Abstract][Full Text] [Related]
25. Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms.
Suttorp M; Schmitz N; Dreger P; Schaub J; Löffler H
Leukemia; 1993 May; 7(5):679-87. PubMed ID: 8097800
[TBL] [Abstract][Full Text] [Related]
26. Detection of mixed chimerism and leukemic relapse after allogeneic bone marrow transplantation in subpopulations of leucocytes by fluorescent in situ hybridization in combination with the simultaneous immunophenotypic analysis of interphase cells.
Kögler G; Wolf HH; Heyll A; Arkesteijn G; Wernet P
Bone Marrow Transplant; 1995 Jan; 15(1):41-8. PubMed ID: 7742754
[TBL] [Abstract][Full Text] [Related]
27. Conventional cytogenetics and FISH evaluation of chimerism after sex-mismatched bone marrow transplantation (BMT) and donor leukocyte infusion (DLI).
Díez-Martín JL; Llamas P; Gosálvez J; López-Fernández C; Polo N; de la Fuente MS; Buño I
Haematologica; 1998 May; 83(5):408-15. PubMed ID: 9658724
[TBL] [Abstract][Full Text] [Related]
28. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
[TBL] [Abstract][Full Text] [Related]
29. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of STR-PCR and FISH value for monitoring chimerism after sex-mismatched allogeneic hematopoietic stem cell transplantation].
Qin YW; Jiang Y; Wang XR; Wan LP; Yan SK; Wang C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1016-20. PubMed ID: 19698250
[TBL] [Abstract][Full Text] [Related]
31. Mixed chimerism of the resident macrophage population after allogeneic bone marrow transplantation for chronic myeloid leukemia.
Wickenhauser C; Thiele J; Pérez F; Varus E; Stoffel MS; Kvasnicka HM; Beelen DW; Schaefer UW
Transplantation; 2002 Jan; 73(1):104-11. PubMed ID: 11792988
[TBL] [Abstract][Full Text] [Related]
32. Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia.
Seong CM; Giralt S; Kantarjian H; Xu J; Swantkowski J; Hayes K; Glassman AB; Khouri I; Korbling M; Thall P; Siciliano MJ; Champlin RE
J Clin Oncol; 2000 May; 18(9):1831-6. PubMed ID: 10784623
[TBL] [Abstract][Full Text] [Related]
33. Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation.
Chiorean EG; DeFor TE; Weisdorf DJ; Blazar BR; McGlave PB; Burns LJ; Brown C; Miller JS
Biol Blood Marrow Transplant; 2004 Mar; 10(3):171-7. PubMed ID: 14993882
[TBL] [Abstract][Full Text] [Related]
34. Peripheral blood late mixed chimerism in leucocyte subpopulations following allogeneic stem cell transplantation for childhood malignancies: does it matter?
Pichler H; Fritsch G; König M; Daxberger H; Glogova E; Pötschger U; Breuer S; Lawitschka A; Güclü ED; Karlhuber S; Holter W; Haas OA; Lion T; Matthes-Martin S
Br J Haematol; 2016 Jun; 173(6):905-17. PubMed ID: 26996395
[TBL] [Abstract][Full Text] [Related]
35. Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning.
Baron F; Sandmaier BM
Leukemia; 2006 Oct; 20(10):1690-700. PubMed ID: 16871276
[TBL] [Abstract][Full Text] [Related]
36. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.
Amare PS; Baisane C; Saikia T; Nair R; Gawade H; Advani S
Cancer Genet Cytogenet; 2001 Dec; 131(2):125-34. PubMed ID: 11750052
[TBL] [Abstract][Full Text] [Related]
37. Donor Chimerism of B Cells and Nature Killer Cells Provides Useful Information to Predict Hematologic Relapse following Allogeneic Hematopoietic Stem Cell Transplantation.
Jiang Y; Wan L; Qin Y; Wang X; Yan S; Xie K; Wang C
PLoS One; 2015; 10(7):e0133671. PubMed ID: 26226104
[TBL] [Abstract][Full Text] [Related]
38. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation.
Pérez-Simón JA; Caballero D; Diez-Campelo M; Lopez-Pérez R; Mateos G; Cañizo C; Vazquez L; Vidriales B; Mateos MV; Gonzalez M; San Miguel JF
Leukemia; 2002 Aug; 16(8):1423-31. PubMed ID: 12145680
[TBL] [Abstract][Full Text] [Related]
39. Early phase mixed chimerism in bone marrow does not affect long-term outcomes of myeloablative single-unit cord blood transplantation for adult patients with hematological malignancies.
Konuma T; Kato S; Oiwa-Monna M; Ishii H; Tojo A; Takahashi S
Leuk Lymphoma; 2016 Dec; 57(12):2848-2854. PubMed ID: 27124418
[TBL] [Abstract][Full Text] [Related]
40. Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions.
Sairafi D; Remberger M; Uhlin M; Ljungman P; Ringdén O; Mattsson J
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1728-37. PubMed ID: 20542125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
